Medtronic, Inc. Will Appeal Jury Verdict

MEMPHIS, Tenn.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) announced today that it will appeal a verdict from a federal jury in Boston that its VERTEX® line of multi-axial pedicle screws infringe, under the doctrine of equivalents, a patent licensed to DePuy Spine, a division of Johnson & Johnson. Under the verdict, the jury found $226.3 million in damages to DePuy. The verdict is not yet final and is subject to post-trial rulings on certain of Medtronic’s defenses. When and if the judgment is entered by the court, Medtronic will appeal.
MORE ON THIS TOPIC